— Know what they know.
Not Investment Advice

476060.KQ KOE

Onconic Therapeutics
1W: +3.8% 1M: -12.7% 3M: +14.8% YTD: -8.8% 1Y: -37.8%
₩15,710.00 ($11.69)
-210.00 (-1.32%)
 
Weekly Expected Move ±6.2%
₩13769 ₩14739 ₩15710 ₩16681 ₩17651
KOE · Healthcare · Biotechnology · Tech Score Buy · Power 46 · ₩173.9B mcap · 5M float · 10.03% daily turnover

📊 Key Metrics

TTM
₩82B
Revenue
+199.5% YoY
₩24B
Net Income
+229.9% YoY
₩16B
Free Cash Flow
+2574.0% YoY
42.4%
Gross Margin
11.4%
Op. Margin
15.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE33.5%
ROA31.0%
ROIC80.6%

Valuation

P/E28.9
P/B8.3
EV/EBITDA29.2

Leverage

Debt/Equity0.00
Current Ratio11.39
Interest Cov.2043.7x

Quality Scores

Piotroski F5/9
Altman Z54.39
Beneish M0.24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms